Mehrez A, Gafni A
Faculty of Business, McMaster University, Hamilton, Ontario, Canada.
Med Decis Making. 1989 Apr-Jun;9(2):142-9. doi: 10.1177/0272989X8900900209.
Decisions about medical treatments and the settings of health programs are not purely technical, but also involve issues of value such as the evaluation of trade-offs between quality of life (morbidity) and quantity of life (mortality). The most commonly used measure of outcome in such cases is the quality-adjusted life year (QALY). The authors show that QALYs, being a health status index, do not stem directly from the individual's utility function and thus only partly reflect the individual's true preferences. This might lead to the choice of the nonpreferred alternative due to the misrepresentation of the individual's preferences. Two examples illustrate this claim. An alternative measure of outcome, the healthy-years equivalent (HYE), is described. This measure stems directly from the individual's utility function and thus fully reflects his/her preferences. It combines outcomes of both morbidity and mortality and thus can serve as common unit of measure for all programs, allowing comparisons across programs. Different ways of measuring the HYE are discussed.
关于医疗治疗和健康项目设置的决策并非纯粹技术性的,还涉及价值问题,比如对生活质量(发病率)和生命数量(死亡率)之间权衡的评估。在这种情况下,最常用的结果衡量指标是质量调整生命年(QALY)。作者表明,作为一种健康状况指数,QALY并非直接源于个体的效用函数,因此只能部分反映个体的真实偏好。这可能会因个体偏好的错误呈现而导致选择非首选方案。文中给出了两个例子来说明这一观点。还介绍了一种替代的结果衡量指标,即健康年限当量(HYE)。该指标直接源于个体的效用函数,因此能充分反映其偏好。它综合了发病率和死亡率的结果,因此可以作为所有项目的通用衡量单位,便于跨项目比较。文中还讨论了测量HYE的不同方法。